Abstract
OBJECTIVE: Posttransplant lymphoproliferative disease (PTLD) is an important source of morbidity and mortality in transplant recipients. Risk factors are thought to include immunosuppressive agents and viral infection. This study was designed to evaluate the impact of different immunosuppressive agents, ganciclovir and calcium channel blocker use in the development of PTLD.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
